Come up with a name for your new list and we'll add to it:
Mutabilis raised a round of funding on September 20, 2012. Investors include
Seventh Framework Programme.
Mutabilis is a biopharmaceutical company specialised in antibacterial drugs. It was founded in 2001 by Xavier Nassif, professor of microbiology at the Necker medical school in Paris and head of Inserm…